Healthcare Triangle Inc 2024年度报告

Form10-K(Amendment No. 1) (Mark One)☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes☐No☒ Indicate by check if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes☐No☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smallerreporting company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerginggrowth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer☐Accelerated filer☐Non-accelerated filer☒Smaller reporting company☒Emerging growthcompany☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectivenessof its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registeredpublic accounting firm that prepared or issued its audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of theregistrant included in the filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes☐No☒ The aggregate market value of voting stock held by non-affiliates of the registrant on June 30, 2023, based on the closing price of$2.33 for shares of the registrant’s common stock as reported by The Nasdaq Stock Market, was approximately $3,723,021. Shares ofcommon stock beneficially owned by each executive officer and director have been excluded in that such persons may be deemed tobe affiliates. As of February 14, 2025,6,401,824shares of the registrant’s common stock, $0.00001 par value per share, were issued andoutstanding. Table of Contents PART I – FINANCIAL INFORMATIONItem 1 Business1Item 1A Risk Factors11Item 1B Unresolved Staff Comments32Item 1C Cybersecurity32Item 2 Properties33Item 3 Legal Proceedings33Item 4 Mine Safety Disclosures33PART IIItem 5 Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of EquitySecurities34Item 6 [Reserved]35Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations36Item 8 Financial Statements and Supplementary DataF-1Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure48Item 9A Controls and Procedures48Item 9B Other Information49Item 9C Disclosure Regarding Foreign Jurisdictions that Prevent Inspections49PART IIIItem 10 Directors, Executive Officers and Corporate Governance50Item 11 Executive Compensation56Item 12 Security ownership of Certain Beneficial Owners and Management and Related Stockholder Matters57Item 13 Certain Relationships and Related party Transactions, and Director Independence59Item 14 Principal Accounting Fees and Services59PART IVItem 15 Exhibit and Financial Statement Schedules60 EXPLANATORY NOTE This Annual Report on Form 10-K (this “Form 10-K”) of Healthcare Triangle, Inc., a Delaware corporation, (the “Company,”“we,” “our,” or “us”) for the year ended December 31, 2023, includes consolidated comparative financial statements anddisclosures which have been restated from the Form 10-K previously filed for the year ended December 31, 2023, with theSecurities and Exchange Commission (the “SEC”) on March 18, 2024 (the “2023 Original Filing”). Restatement of the Financial Statement for Fiscal Year Ended December 31, 2023 This Form 10-K restates the 2023 Original Filing and related disclos